Replies to post #11313 on DNAprint Genomics (DNAG)

[mingwan0]

Jim, that sort of model would work. There are certain GAAP rules that have to be followed in pooled interest accounting (12 of them) but it is a good way to circumvent issues associated with purchasing another entity outright.

OT: Your choice of XKEM is not a good one IMO (I know you have posted on that board for a long time). I believe that XKEM is a sophisticated scam and that Dr. Pandey is essentially a crook. I know that opinions differ on this one, and that they have the sickle cell drug (Nisipran), they just did the Ceptor acquisition, etc, but...